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The proliferation of vascular smooth muscle cells (VSMCs) within the artery wall is a
hallmark of the atherosclerotic process. The entrance of VSMCs from the resting G0-
phase of the cell cycle into the G1/S proliferative phases depends on the activity of sev-
eral cyclin-dependent protein kinase (CDK) haloenzymes. In resting cells, cyclin-CDK
complexes are inhibited by the CDK-inhibitors (CKIs), including p27/Kip1.
In animal models, p27/Kip1 ablation in apolipoprotein E-null mice challenged with an
atherogenic diet enhanced arterial cell proliferation and accelerated atherogenesis.
Therefore, p27/Kip1 is a candidate-gene to modify the risk of developing atherosclero-
sis, such that genetic variation at p27/Kip1 could influence the individual risk to suffering
coronary artery disease. A total of 180 DNAs of human patients who had suffered an
episode of myocardial infarction were obtained.
All these patients were male, 55 years old or younger. Single-strand conformation analy-
sis was used to study the entire p27/Kip1-coding sequence, as well as 1,150 nucleotides
of the promoter region.  For those samples showing atypical electrophoretic patterns
the amplified fragment was sequenced. We identified 3 SNPs: –840 (A/C); –79 (C/T) and
+326 G/T (Val109Gly).
Patients and 250 controls (males and younger than 55 years) were analysed for these
polymorphisms. We found a significantly higher frequency of the -840AA genotype in
patients, compared to controls (OR=1.75; 95%CI=1.08-2.82). Luciferase reporter gene
assays with both alleles showed a low luciferase levels of allele A compared with allele C
(p=0.04). Thus, given the important role of p27/kip1 as an inhibitor of VSMC prolifera-
tion and atheroma development, we suggest that genetic variation of the p27/kip1 gene
leading to reduced promoter activity could be a genetic risk factor predisposing to
myocardial infarction.
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